View Clinical Trial (Medical Research Study)

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS) - NCT00907153-17033(Clinical Trial 293776)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Hershey
State:  
PA
Zip Code: 17033
Conditions: Polycystic Ovary Syndrome
Purpose: The purpose of this study is to determine if vitamin D will improve insulin resistance, inflammation, and overall well-being in women with PCOS.
Study summary: As many cells throughout the body possess the vitamin D receptor, adequate vitamin D levels may be essential for multiple physiologic functions. In recent years, vitamin D insufficiency has been linked to insulin resistance, inflammation, poor psychological health, obesity, type 2 diabetes, and cardiovascular disease - these are also commonly found in women with Polycystic Ovary syndrome (PCOS). We believe that vitamin D insufficiency contributes to insulin resistance, inflammation, and psychological distress in women with PCOS. These adverse effects may ultimately increase the risk for serious long-term complications in PCOS, including type 2 diabetes and cardiovascular disease. The key objectives of this research study are to determine the effects of vitamin D supplementation on insulin resistance, inflammation, mood and overall well-being in women with PCOS.
Criteria: Inclusion Criteria: - Diagnosis of PCOS based on: - Eight or fewer menstrual periods per year or spontaneous intermenstrual periods of greater than or equal to 45 days, and - Elevated testosterone levels Exclusion Criteria: - Current Pregnancy or Nursing - Elevated calcium - Kidney Stones or kidney disease - Current use of vitamin D (other than a multivitamin) - Use of metformin or other insulin sensitizing drugs in the last 3 months - Elevated prolactin or untreated thyroid disease - Diabetes, Liver disease, Heart disease, or other serious medical condition
Study is available at: Penn State College of Medicine, Penn State Milton S Hershey Medical Center
Hershey, PA 17033
United States

Primary Contact:
Barb Scheetz, B.S.
Email: bscheetz@psu.edu
Phone: 717-531-4483

Secondary Contact:
Barb Scheetz, B.S.
Email: bscheetz@psu.edu
Phone: 717-531-4483
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.